Global Health Happenings: Brazilian Pharmaceutical Market Entry and Indian Cough Syrup Crisis
Recent health news highlights include MercadoLibre's entry into Brazil's online medicine market, India's declaration of toxic cough syrups causing child deaths, Porr's acquisition of VAMED's Austrian assets, and WHO's warning on India's regulatory gap in syrup testing. Meanwhile, Ottobock's IPO signals growth in the prosthetics sector.

MercadoLibre, Latin America's e-commerce giant, plans to penetrate Brazil's lucrative online medicine market. This move comes after its acquisition of a local drugstore, marking the company's first pharmaceutical venture in its main market. Previously, MercadoLibre sold medicines online in Mexico, Argentina, Chile, and Colombia.
In a stark revelation, India has classified three cough syrups as toxic following the deaths of 17 children. The World Health Organization criticized India's failure to screen locally-manufactured syrups, citing a regulatory gap. All fatalities were linked to a product containing dangerous levels of diethylene glycol.
German prosthetics firm Ottobock made a strong debut on the Frankfurt Stock Exchange, exceeding its initial public offering price. The company aims to raise significant capital to further cement its position as the world's leading artificial limb manufacturer, highlighting growth in the global health sector.
(With inputs from agencies.)
- READ MORE ON:
- MercadoLibre
- Brazil
- pharmacy
- India
- cough syrup
- toxic
- Ottobock
- IPO
- protesthetics
- WHO
ALSO READ
Toxic Alert in Manipur: Banned Cough Syrups Contain Lethal Solvent
Cough Syrup Crisis: Tragedy in Tamil Nadu Shakes India
Tamil Nadu's Timely Intervention Prevents Cough Syrup Tragedy
Urgent Recall Demanded for Hazardous Cough Syrups
CDSCO Tightens Grip: Nationwide Audit of Cough Syrup Manufacturers Post Tragedy